Marc Blondon1, Michael Sachs, Andrew N Hoofnagle, Joachim H Ix, Erin D Michos, Claudia Korcarz, Adam D Gepner, David S Siscovick, Joel D Kaufman, James H Stein, Bryan Kestenbaum, Ian H de Boer. 1. From the Department of Epidemiology (M.B., D.S.S., J.D.K., B.K., I.H.d.B.), Division of Nephrology and Kidney Research Institute (M.S., B.K., I.H.d.B.), Department of Laboratory Medicine (A.N.H.), Department of Environmental and Occupational Health Sciences (J.D.K.), Department of Medicine (D.S.S., J.D.K., B.K., I.H.d.B.), Cardiovascular Health Research Unit (M.B., D.S.S.), University of Washington, Seattle, WA; Department of Medicine, Geneva University Hospitals, Geneva, Switzerland (M.B.); Division of Nephrology, University of California, San Diego, CA (J.H.I.); Department of Medicine, Johns Hopkins University, Baltimore, MD (E.D.M.); and Divison of Cardiovascular Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI (C.K., A.D.G., J.H.S.).
Abstract
OBJECTIVE: Observational evidence supports independent associations of 25-hydroxyvitamin D (25-OHD) and parathyroid hormone (PTH) with cardiovascular risk. A plausible hypothesis for these associations is accelerated development of atherosclerosis. APPROACH AND RESULTS: We evaluated cross-sectional and longitudinal associations of 25-OHD and PTH with carotid intima-media thickness (IMT) and carotid plaques among 3251 participants free of cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. 25-OHD and PTH were measured at baseline by mass spectrometry and immunoassay, respectively. All subjects underwent a carotid ultrasound examination at baseline and 9.4 years later (median, range 8-11.1 years). Multivariable linear and logistic regressions were used to test associations of 25-OHD and PTH with the extent and progression of IMT and the prevalence and incidence of carotid plaque. Mean (SD) 25-OHD and PTH were 25.8 ng/mL (10.6) and 44.2 pg/mL (20.2), respectively. No independent associations were found between 25-OHD or PTH and IMT at baseline (increment of 1.9 μm [95% confidence interval, -5.1 to 8.9] per 10 ng/mL lower 25-OHD; increment of 0.8 μm [95% confidence interval, -3.2 to 4.8] per 10 pg/mL higher PTH) or progression of IMT (increment of 2.6 μm [95% confidence interval, -2.5 to 7.8] per 10 ng/mL lower 25-OHD, increment of 1.6 μm [95% confidence interval, -1.9 to 5.2] per 10 pg/mL higher PTH). No associations were found with the baseline prevalence of carotid plaque or the incidence of new plaques during the study period. We did not observe any interaction by race or ethnicity (White, Chinese, Black, and Hispanic). CONCLUSIONS: The consistent lack of association of vitamin D and PTH with carotid IMT and plaque suggests that these hormones may influence cardiovascular risk through pathways not reflected by carotid atherosclerosis.
OBJECTIVE: Observational evidence supports independent associations of 25-hydroxyvitamin D (25-OHD) and parathyroid hormone (PTH) with cardiovascular risk. A plausible hypothesis for these associations is accelerated development of atherosclerosis. APPROACH AND RESULTS: We evaluated cross-sectional and longitudinal associations of 25-OHD and PTH with carotid intima-media thickness (IMT) and carotid plaques among 3251 participants free of cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. 25-OHD and PTH were measured at baseline by mass spectrometry and immunoassay, respectively. All subjects underwent a carotid ultrasound examination at baseline and 9.4 years later (median, range 8-11.1 years). Multivariable linear and logistic regressions were used to test associations of 25-OHD and PTH with the extent and progression of IMT and the prevalence and incidence of carotid plaque. Mean (SD) 25-OHD and PTH were 25.8 ng/mL (10.6) and 44.2 pg/mL (20.2), respectively. No independent associations were found between 25-OHD or PTH and IMT at baseline (increment of 1.9 μm [95% confidence interval, -5.1 to 8.9] per 10 ng/mL lower 25-OHD; increment of 0.8 μm [95% confidence interval, -3.2 to 4.8] per 10 pg/mL higher PTH) or progression of IMT (increment of 2.6 μm [95% confidence interval, -2.5 to 7.8] per 10 ng/mL lower 25-OHD, increment of 1.6 μm [95% confidence interval, -1.9 to 5.2] per 10 pg/mL higher PTH). No associations were found with the baseline prevalence of carotid plaque or the incidence of new plaques during the study period. We did not observe any interaction by race or ethnicity (White, Chinese, Black, and Hispanic). CONCLUSIONS: The consistent lack of association of vitamin D and PTH with carotid IMT and plaque suggests that these hormones may influence cardiovascular risk through pathways not reflected by carotid atherosclerosis.
Entities:
Keywords:
atherosclerosis; carotid artery diseases; carotid intima-media thickness; mineral metabolism; parathyroid hormone; plaque, atherosclerotic; vitamin D
Authors: Michael C Sachs; John D Brunzell; Patricia A Cleary; Andrew N Hoofnagle; John M Lachin; Mark E Molitch; Michael W Steffes; Bernard Zinman; Ian H de Boer Journal: Diabetes Care Date: 2013-03-25 Impact factor: 19.112
Authors: Stefan Pilz; Nicolas Verheyen; Martin R Grübler; Andreas Tomaschitz; Winfried März Journal: Nat Rev Cardiol Date: 2016-05-06 Impact factor: 32.419
Authors: Anand Vaidya; Gary C Curhan; Julie M Paik; Henry Kronenberg; Eric N Taylor Journal: J Clin Endocrinol Metab Date: 2015-04-17 Impact factor: 5.958
Authors: Rebecca Stern; Matthew C Tattersall; Adam D Gepner; Claudia E Korcarz; Joel Kaufman; Laura A Colangelo; Kiang Liu; James H Stein Journal: Arterioscler Thromb Vasc Biol Date: 2014-12-04 Impact factor: 8.311
Authors: Aaron R Folsom; Alvaro Alonso; Jeffrey R Misialek; Erin D Michos; Elizabeth Selvin; John H Eckfeldt; Josef Coresh; James S Pankow; Pamela L Lutsey Journal: Am Heart J Date: 2014-06-09 Impact factor: 4.749
Authors: Adam D Gepner; Laura A Colangelo; Marc Blondon; Claudia E Korcarz; Ian H de Boer; Bryan Kestenbaum; David S Siscovick; Joel D Kaufman; Kiang Liu; James H Stein Journal: Arterioscler Thromb Vasc Biol Date: 2014-04-03 Impact factor: 8.311